Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review.
about
Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes.Pharmacotherapy of 'treatment resistant' type 2 diabetes.Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association.Pharmacological management of type 2 diabetes: what's new in 2017?
P2860
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Efficacy and safety of insulin ...... mellitus: a systematic review.
@ast
Efficacy and safety of insulin ...... mellitus: a systematic review.
@en
type
label
Efficacy and safety of insulin ...... mellitus: a systematic review.
@ast
Efficacy and safety of insulin ...... mellitus: a systematic review.
@en
prefLabel
Efficacy and safety of insulin ...... mellitus: a systematic review.
@ast
Efficacy and safety of insulin ...... mellitus: a systematic review.
@en
P2093
P2860
P1476
Efficacy and safety of insulin ...... mellitus: a systematic review.
@en
P2093
D Cimmaruta
K Esposito
L Sportiello
M I Maiorino
P2860
P356
10.1080/14740338.2016.1221402
P407
P577
2016-12-01T00:00:00Z